Details for New Drug Application (NDA): 018746
✉ Email this page to a colleague
The generic ingredient in VASOCON-A is antazoline phosphate; naphazoline hydrochloride. Additional details are available on the antazoline phosphate; naphazoline hydrochloride profile page.
Summary for 018746
Tradename: | VASOCON-A |
Applicant: | Novartis |
Ingredient: | antazoline phosphate; naphazoline hydrochloride |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5%;0.05% | ||||
Approval Date: | Jul 11, 1994 | TE: | RLD: | No |
Complete Access Available with Subscription